Paul Mintz

Paul Mintz discloses dealings in 2 companies, chiefly Nuo Therapeutics, Inc. and Immucor Inc. In total, 8 filings cover trades dated from 7 June 2010 to 9 December 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 11 December 2025, the filings show a share grant worth €17k in Nuo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.